Midi clinicians are trained to address the effects of hormonal change, including stubborn weight gain, so you never have to go it alone
A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes
The cost of independent testing typically runs between 150 and 400 dollars depending on the analytical methods used
Right-upper-abdominal pain, fever, vomiting, or jaundice usually requires medical evaluation and often ultrasound or other imaging